NACOGDOCHES, Texas (PRESS RELEASE) - This notice has been issued due to a large leak on FM 343/CR 821, the Texas Commission on Environmental Quality has required the Lilly Grove SUD #1740014, public ...

Eli ⁠Lilly said on Monday it would acquire privately held Merida Biosciences for up to $2.88 billion in cash, strengthening its immunology portfolio with an experimental treatment for thyroid-related ...

The Food and Drug Administration approved Eli Lilly's diabetes drug Mounjaro to cut down the risk of heart attack or stroke in high-risk adults with Type 2 diabetes. The approval gives consumers ...

LLY delivered 48% revenue growth and raised full-year EPS guidance, yet shares sit nearly 30% below the $1,500 price target within reach. Retatrutide's BLA filing, Foundayo scaling past 36,000 ...

Deal helps Lilly expand immunology pipeline, diversify beyond obesity drugs Merida's lead drug candidate targets Graves' disease and thyroid eye disease Transaction valued at up to $2.88 billion in ...

Eli Lilly remains on a shopping spree, agreeing to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio. Eli Lilly ...

Eli Lilly (LLY +2.69%) has achieved impressive returns in recent years, driven by soaring demand for tirzepatide, a medicine sold as Mounjaro for diabetes and Zepbound (in certain markets) for obesity ...

ALLENTOWN, Pa. - With only 535 current Lehigh Valley housing listings, the west end Allentown sale is an example of a hot seller’s market, even in the dead of winter. "This house sold in a day?" 69 ...

Acquisition strengthens Lilly's immunology capabilities and its opportunity to elevate the standard of care for immune-mediated conditions with high unmet need INDIANAPOLIS and CAMBRIDGE, Mass., Aug.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...